Affirm Holdings reported fiscal Q4 results on August 25 and exits earnings week with shorts in clear retreat, borrow conditions comfortably loose, and options traders still carrying more defensive positioning than usual — a split that makes the next few sessions worth watching carefully.
The short-cover trend that was already visible into the print has continued. Short interest has dropped 23% over the past month, falling to around 4.8% of free float — the lowest level in the 30-day data window, down from nearly 6.3% in mid-July. The magnitude of the unwind is notable: from roughly 18.7 million shares short in mid-July to just under 13.9 million today. Borrow conditions back this up — availability has expanded sharply, now running at 1,491% relative to current short interest, well up from the 550-700% range seen six weeks ago, meaning the lending pool has far more supply than demand. Cost to borrow ticked up 49% on the week to 0.47%, but that follows a period of sustained compression and remains firmly in "low" territory. The ORTEX short score has also eased from 43 to 40.8 over the past two weeks, consistent with pressure coming off the short side. Taken together, the lending market tells a story of bears retreating rather than pressing.
Options positioning complicates that picture. The put/call ratio climbed to 1.18, more than two standard deviations above its 20-day average of 1.09 — close to its 52-week high of 1.23. That's a higher-than-usual demand for downside protection, even as the stock gained 6% on the week to $77.95 and is up 11% over the past month. The divergence between shorts covering and options buyers hedging is the central tension here: one group is reducing bearish exposure, the other is adding it.
The Street remains broadly constructive. Morgan Stanley raised its target to $80 this morning while holding an Equal-Weight rating — a signal of modest confidence rather than conviction. Oppenheimer was more direct on Monday, lifting its target from $87 to $100 with an Outperform. The consensus mean sits at $91.67, roughly 18% above the current price, with multiple buy-equivalent ratings from Goldman ($106 target), JPMorgan ($90), Wells Fargo ($96), and Bernstein ($100). Bulls emphasise the BNPL leadership position, the Amazon and Shopify partnership anchors, and the potential for an industrial loan charter to compress funding costs materially. Bears point to US revenue concentration, macro headwinds to consumer credit, and execution risk around the banking charter application. The PE multiple of 18x and EV/EBITDA around 18x are not demanding for a company where 90-day earnings momentum ranks in the 96th percentile — though near-term EPS surprise history is weaker, ranking in just the 25th percentile.
On the ownership side, JP Morgan Asset Management added nearly 9.9 million shares in the most recent reporting period — a meaningful addition that brings its total to 14.4 million shares. Capital Research remained the largest institutional holder at 14.7% of shares, and also added to its position. Insider activity has been routine: small scheduled sells from the President and COO in late July at $71.51, and a modest director sale in August at $77.86, all low-significance. Net insider flow over 90 days is marginally positive but driven by award activity rather than open-market conviction buying.
The earnings reaction history for Affirm offers limited reassurance. The prior two events both produced next-day declines of 1.4% and 2.4% respectively, though one recovered to a modest five-day gain. Whether Tuesday's Q4 print disrupts the short-cover narrative or validates the cautious options hedging is the central question for the week ahead.
See the live data behind this article on ORTEX.
Open AFRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
